Penn State University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Penn State University sits in the top decile of US sponsors by registered trial count (#147 of 15,742 sponsors by registered trial count).
Penn State University: 219 sponsored US clinical trials, 37 recruiting.
Penn State University sponsors 219 registered US clinical trials on ClinicalTrials.gov, 37 of them currently recruiting, and 151 completed. 10 of these trials are in Phase 3-4 (later-stage) and 32 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cardiovascular Disease, with 7 trials.
Top-decile sponsor footprint
Penn State University ranks in the top decile of sponsors by registered trial count (#147 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
151 of 163 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
219 total, page 4 of 5
Canola Oil Multi-center Intervention Trial II
NCT03054779
Effects of Walnuts on Central Blood Pressure, Arterial Stiffness Indices, Lipoproteins, and Other CVD Risk Factors
NCT02210767
Healthy Mom Zone: A Gestational Weight Gain Management Intervention
NCT03945266
Effects of a Prescription Omega-3 Fatty Acid Concentrate on Induced Inflammation
NCT01813110
Effect of Soy on HDL-C Function, Central Blood Pressure, and Arterial Stiffness
NCT02180841
Effect of Portion-control Training on Food Intake
NCT02942589
Physical Activity and Daily Experiences Study
NCT02005042
Effect of Strawberries on Cardiovascular Disease Risk
NCT01989637
Effects of Portion Size and Energy Density of a Single Meal in Preschool Children
NCT02299531
Effects of Portion Size of Multiple Items at a Meal on Food Intake of Adults
NCT02369588
Effect of Agave Syrup, Placebo, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Infants/Toddlers and Their Parents
NCT01721395
Portion Size Strategies for Management of Body Weight
NCT01474759
Influence of a Delivery System on the Efficacy of a Probiotic Intervention
NCT01399996
Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors
NCT01882881
Attention and Social Behavior in Children
NCT02401282
Dose Response Effects of Marine Omega-3 Fatty Acids on Inflammation
NCT01078909
The Effects of Peanuts and Peanut Products on Glucose Control and Vascular Function
NCT01405300
Safety and Feasibility of an Endotoxemia Model
NCT01329965
Increasing the Variety of Vegetables and Fruits Served to Preschool Children at a Snack
NCT01557218
Cognitive Intervention For Delirium in Dementia
NCT01267682
The Effect of Avocado on Cardiovascular Disease (CVD) Risk Factors
NCT01235832
Canola Oil Multicentre Intervention Trial (COMIT)
NCT01233778
Varying the Energy Density and Portion Size of the Main Course After a First-course Salad
NCT01729390
Reducing Energy Density by Different Methods to Decrease Energy Intake
NCT01470300
Early Nurse Detection and Management of Delirium
NCT01505257
A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis
NCT01016223
Cue-based Tactile Stimulation and Infant Stress Reactivity
NCT01121523
Children's Intake of Foods Reduced in Energy Density
NCT01252433
Reducing Dietary Energy Density by Incorporating Vegetables in Order to Decrease Energy Intake
NCT01165086
Effects of Almonds on Cardiovascular Risk Factors
NCT01101230
Effects of Pistachios on Cardiovascular Responses to Stress in Type 2 Diabetes
NCT00956735
Effects of Antioxidants on Cardiovascular Risk Measures (Spice Study)
NCT00954902
Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides
NCT01173042
Tweens to Teens Project at Penn State
NCT01184651
Disseminating Effective Habits for Long-Term Weight Loss
NCT00709501
Vitamin D Supplementation in Crohn's Patients
NCT00742781
Patient Outcomes With Endoscopic Versus Open Carpal Tunnel Release
NCT00880295
Grains Reduce Adiposity and Improve Nutrition Study
NCT00924521
Healthy Fatty Acids in Transition
NCT00937963
Beef in an Optimal Lean Diet (BOLD) Effects on Metabolic Syndrome
NCT00937638
Energy Content and Energy Density of Pre-portioned Entrees
NCT01349023
Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
NCT00743990
Measurement of the Eye's Blood Vessels Using the Dynamic Vessel Analyzer (DVA)
NCT00783029
The Effects of Bariatric Surgery Weight Loss on Knee Pain in Patients With Osteoarthritis of the Knee
NCT00752765
Correlation Between Release of Cytokines From Liver Graft and Hemodynamic Instability
NCT01120743
Adaptation Processes in School-Based Substance Abuse Programs
NCT01755533
Retrobulbar Injection of Anesthesia Versus Healon 5 in the Management of Intraoperative Floppy Iris Syndrome
NCT00627913
The Effect of Processed Tomato Products on CVD Risks
NCT00937742
Postprandial Effects of Walnut Components Versus Whole Walnuts on Cardiovascular Disease (CVD) Risk Reduction
NCT00938340
Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides
NCT00504309
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 11 |
| Phase 3 | 2 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Penn State University pipeline
37 recruiting of 219 indexed (17% open); 151 completed (69%).
Phase mix: 10 late (III/IV) vs 32 early (I/II) (early-phase heavy).
Top condition: Cardiovascular Disease (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Penn State University: open-pipeline peers nationwide
Peers matched on 219 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Penn State University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 219 trials (± recruiting share)
- Florida State University · 219 trials · 21% recruiting
- National Eye Institute (NEI) · 221 trials · 8% recruiting
- Otsuka Pharmaceutical Development & Commercialization · 221 trials · 4% recruiting
- University of Louisville · 217 trials · 21% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
- NYU Langone Health · 17% recruiting · 1,164 trials
Related
What to do with this Penn State University page
219 registered trials is a research-attention snapshot, not an endorsement of Penn State University or any single study.
- 37 of Penn State University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cardiovascular Disease is the condition Penn State University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cardiovascular Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Penn State University pipeline card: 219 registered trials from official public datasets.Report a data error.